Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8 + T cells in human cutaneous leishmaniasis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2567 (Electronic) Linking ISSN: 00192805 NLM ISO Abbreviation: Immunology Subsets: MEDLINE
    • Publication Information:
      Original Publication: Oxford : Blackwell Scientific Publications
    • Subject Terms:
    • Abstract:
      Cytotoxic activity mediated by CD8 + T cells is the main signature of the immunopathogenesis of cutaneous leishmaniasis (CL). Here, we performed a broad evaluation of natural killer (NK) cell phenotypic and functional features during cutaneous leishmaniasis. We demonstrate for the first time that CL patients present the accumulation of circulating NK cells with multiple features of replicative senescence including low proliferative capacity and shorter telomeres, elevated expression of CD57, KLRG1 but diminished CD27 stimulatory receptor expression. Moreover, they exhibited higher cytotoxic and inflammatory potential than age-matched controls. The accumulation of circulating senescent NK cells (CD56 dim  CD57 bright ) correlated positively with skin lesion size in the same patients, suggesting that they, like circulating senescent CD8 + T cells, may contribute to the immunopathology of CL. However, this senescent population had lower cutaneous lymphocyte antigen expression and so had diminished skin-homing potential compared with total or senescent CD8 + T cells. This was confirmed in CL skin lesions where we found a predominance of CD8 + T cells (both senescent and non-senescent) that correlated with the severity of the disease. Although there was also a correlation between the proportions of senescent NK cells (CD56 +  CD57 + ) in the skin and lesion size, this was less evident. Collectively our results demonstrate first-hand that senescent cytotoxic cells may mediate skin pathology during human cutaneous leishmaniasis. However, as senescent cytotoxic CD8 + T cells predominate in the skin lesions, they may have a greater role than NK cells in mediating the non-specific skin damage in CL.
      (© 2020 John Wiley & Sons Ltd.)
    • Comments:
      Comment in: Immunol Cell Biol. 2020 Jul;98(6):431-433. (PMID: 32406096)
    • References:
      J Immunol. 1999 Jul 1;163(1):466-75. (PMID: 10384150)
      Parasit Vectors. 2017 May 3;10(1):219. (PMID: 28468680)
      J Invest Dermatol. 2015 Jan;135(1):94-101. (PMID: 25036052)
      Front Immunol. 2016 Nov 04;7:445. (PMID: 27867379)
      Nat Biotechnol. 2013 Jun;31(6):545-52. (PMID: 23685480)
      J Immunol. 2016 Oct 1;197(7):2891-2899. (PMID: 27566818)
      Front Immunol. 2013 Dec 30;4:499. (PMID: 24416035)
      PLoS Pathog. 2017 Feb 13;13(2):e1006196. (PMID: 28192528)
      J Immunol. 1997 Nov 1;159(9):4467-73. (PMID: 9379046)
      J Clin Invest. 2002 Aug;110(4):537-48. (PMID: 12189248)
      Infect Immun. 1993 Aug;61(8):3565-9. (PMID: 8335391)
      Blood. 2010 Nov 11;116(19):3865-74. (PMID: 20733159)
      Front Immunol. 2019 Jan 04;9:3001. (PMID: 30662437)
      Front Immunol. 2013 Dec 09;4:422. (PMID: 24367364)
      Parasite Immunol. 2009 Aug;31(8):432-9. (PMID: 19646207)
      Immunology. 2018 Mar 14;:. (PMID: 29542114)
      Mech Ageing Dev. 2000 Dec 20;121(1-3):77-88. (PMID: 11164462)
      J Invest Dermatol. 2013 Jun;133(6):1533-40. (PMID: 23321919)
      Immunology. 2007 Apr;120(4):518-25. (PMID: 17343614)
      Cell Immunol. 2009;254(2):149-54. (PMID: 18835598)
      Eur J Dermatol. 2008 Nov-Dec;18(6):647-50. (PMID: 18955198)
      PLoS Pathog. 2013;9(7):e1003504. (PMID: 23874205)
      Clin Exp Immunol. 2009 Sep;157(3):377-84. (PMID: 19664146)
      Hum Pathol. 2014 May;45(5):1084-91. (PMID: 24746215)
      PLoS Pathog. 2014 Feb 27;10(2):e1003970. (PMID: 24586170)
      Nat Commun. 2019 Jun 3;10(1):2387. (PMID: 31160572)
      Infect Immun. 1994 Mar;62(3):837-42. (PMID: 8112853)
      J Infect Dis. 2020 Mar 2;221(6):973-982. (PMID: 31748808)
      Parasite Immunol. 2016 Apr;38(4):244-54. (PMID: 26928901)
      Am J Trop Med Hyg. 2009 Sep;81(3):378-83. (PMID: 19706899)
      Infect Immun. 1998 Jun;66(6):2698-704. (PMID: 9596736)
    • Grant Information:
      MR/N017749/1 United Kingdom MRC_ Medical Research Council; MR/P00184X/1 United Kingdom MRC_ Medical Research Council; 72939273/16 United Kingdom MRC_ Medical Research Council; MR/T015853/1 United Kingdom MRC_ Medical Research Council; MR/M003833/1 United Kingdom MRC_ Medical Research Council
    • Contributed Indexing:
      Keywords: Leishmania braziliensis; CD8+ T cells; cellular senescence; cutaneous leishmaniasis; immunopathology; natural killer cells
    • Accession Number:
      0 (6-sulfo sialyl Lewis X)
      0 (CD56 Antigen)
      0 (CD57 Antigens)
      0 (KLRG1 protein, human)
      0 (Lectins, C-Type)
      0 (NCAM1 protein, human)
      0 (Oligosaccharides)
      0 (Receptors, Immunologic)
      0 (Sialyl Lewis X Antigen)
      82115-62-6 (Interferon-gamma)
    • Publication Date:
      Date Created: 20200112 Date Completed: 20200727 Latest Revision: 20210402
    • Publication Date:
      20231215
    • Accession Number:
      PMC7078002
    • Accession Number:
      10.1111/imm.13173
    • Accession Number:
      31925782